M. Bouwhuis

发表

The emergency department arrival mode and its relations to ED management and 30-day mortality in acute heart failure: an ancillary analysis from the EURODEM study

Ò. Miró, R. Body, C. Kill, 2022, BMC Emergency Medicine.

Patient satisfaction, needs, and preferences concerning information dispensation at the emergency department: a cross-sectional observational study

J. Haagsma, P. P. Rood, M. Bouwhuis, 2021, International Journal of Emergency Medicine.

Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma.

A. Eggermont, A. V. van Geel, J. D. de Wilt, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Autoimmunity and treatment outcome in melanoma

A. Eggermont, S. Suciu, T. T. ten Hagen, 2011, Current opinion in oncology.

The emergency department arrival mode and its relations to ED management and 30-day mortality in acute heart failure: an ancillary analysis from the EURODEM study

Ò. Miró, R. Body, C. Kill, 2021, BMC Emergency Medicine.

Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-&agr; (EORTC 18 952) and prognostic value on treatment outcome

A. Eggermont, S. Collette, L. Aarden, 2011, Melanoma research.

Effect of written and video discharge instructions on parental recall of information about analgesics in children: a pre/post-implementation study.

J. Haagsma, R. Oostenbrink, P. P. Rood, 2020, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Get with the guidelines: management of chronic obstructive pulmonary disease in emergency departments in Europe and Australasia is sub‐optimal

R. Body, O. Thom, D. Mountain, 2020 .

Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952.

A. Eggermont, V. Cocquyt, P. Patel, 2011, European journal of cancer.

Prognostic value of autoantibodies (auto-AB) in melanoma patients (pts) in the EORTC 18952 trial of adjuvant interferon (IFN) compared to observation (obs)

A. Eggermont, C. Punt, P. Patel, 2007 .

Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.

S. Aamdal, A. Eggermont, C. Punt, 2009, Journal of the National Cancer Institute.

Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991.

A. Eggermont, A. Testori, C. Punt, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunologic functions as prognostic indicators in melanoma

A. Eggermont, M. Bouwhuis, T. L. T. ten Hagen, 2011, Molecular oncology.

Prognostic and predictive value of YKL-40 in stage IIB-III melanoma

I. Christensen, A. Eggermont, H. Schmidt, 2016, Melanoma research.

Diffusion-weighted imaging of edema following traumatic brain injury in rats: effects of secondary hypoxia.

R. Berman, J. Muizelaar, B. Lyeth, 2005, Journal of neurotrauma.

Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma

A. Eggermont, J. D. de Wilt, P. Schmitz, 2007, The British journal of surgery.

Prognostic value of serum YKL-40 in stage IIB-III melanoma patients receiving adjuvant interferon therapy.

S. Aamdal, I. Christensen, A. Eggermont, 2010 .

5LB Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon α2b vs observation

A. Eggermont, A. Testori, C. Punt, 2007 .

Melanoma: Prognostic and Predictive Factors in Interferon Immunotherapy

M. Bouwhuis, 2011 .

Serum concentrations of pegylated interferon α-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon α-2b in a randomized phase III trial (EORTC 18991)

A. Eggermont, A. Testori, A. Yver, 2010, Cancer Chemotherapy and Pharmacology.

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

D. Schadendorf, K. Hemminki, Rajiv Kumar, 2009, Cancer Immunology, Immunotherapy.

Authors' reply: Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma (Br J Surg 2007; 94: 1293–1299)

A. Eggermont, M. Kliffen, J. D. de Wilt, 2008 .

The CAST study protocol: a cluster randomized trial assessing the effect of circumferential casting versus plaster splinting on fracture redisplacement in reduced distal radius fractures in adults

N. Schep, S. Polinder, M. Reijman, 2021, BMC Musculoskeletal Disorders.

How to OPTIMIZE inclusions for emergency department research.

B. Backus, M. Bouwhuis, Eva E. Schippers, 2023, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

D. Schadendorf, K. Hemminki, A. Eggermont, 2009, Cancer Immunology, Immunotherapy.